Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027
CMRAW
CMRAW was delisted on the 15th of November, 2023.
15 hedge funds and large institutions have $24.3K invested in Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
12% less funds holding
Funds holding: 17 → 15 (-2)
24% less capital invested
Capital invested by funds: $31.8K → $24.3K (-$7.48K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$516 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
-$1.14K |
| 2 |
RPWA
Regent Peak Wealth Advisors
Atlanta,
Georgia
|
-$271 |
| 3 |
GS
GTS Securities
New York
|
-$3 |
CMRAW Hedge Fund Activity: Q3 2023 in Review
15 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 (CMRAW) for Q3 2023, worth a combined $24.3K — down 24% from $31.8K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of CMRAW and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Citadel Advisors, adding an estimated $516. The largest seller was Radcliffe Capital Management, exiting entirely with an estimated $1.14K sold.
- 15 institutional investors held Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 (CMRAW) as of Q3 2023, down from 17 in Q2 2023.
- Funds reported $24.3K of Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 stock for Q3 2023, down 24% quarter-over-quarter.
- 0 funds opened new Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 positions in Q3 2023 and 2 closed out, a net change of -2 holders.
- The largest Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 buyer in Q3 2023 was Citadel Advisors, an estimated $516 added.
- The largest Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 seller in Q3 2023 was Radcliffe Capital Management, an estimated $1.14K sold.
Based on aggregated 13F filings for Q3 2023.